Targeting adenosine in cancer immunotherapy to enhance T-cell function
S Vigano, D Alatzoglou, M Irving… - Frontiers in …, 2019 - frontiersin.org
T cells play a critical role in cancer control, but a range of potent immunosuppressive
mechanisms can be upregulated in the tumor microenvironment (TME) to abrogate their …
mechanisms can be upregulated in the tumor microenvironment (TME) to abrogate their …
Immunity, inflammation and cancer: a leading role for adenosine
Cancer is a complex disease that is dictated by both cancer cell-intrinsic and cell-extrinsic
processes. Adenosine is an ancient extracellular signalling molecule that can regulate …
processes. Adenosine is an ancient extracellular signalling molecule that can regulate …
Targeting CD39 in cancer reveals an extracellular ATP-and inflammasome-driven tumor immunity
We explored the mechanism of action of CD39 antibodies that inhibit ectoenzyme CD39
conversion of extracellular ATP (eATP) to AMP and thus potentially augment eATP–P2 …
conversion of extracellular ATP (eATP) to AMP and thus potentially augment eATP–P2 …
[HTML][HTML] A metabolic immune checkpoint: adenosine in tumor microenvironment
A Ohta - Frontiers in immunology, 2016 - frontiersin.org
Within tumors, some areas are less oxygenated than others. Since their home ground is
under chronic hypoxia, tumor cells adapt to this condition by activating aerobic glycolysis; …
under chronic hypoxia, tumor cells adapt to this condition by activating aerobic glycolysis; …
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
Adenosine is a key endogenous molecule that regulates tissue function by activating four G-
protein-coupled adenosine receptors: A1, A2A, A2B and A3. Cells of the immune system …
protein-coupled adenosine receptors: A1, A2A, A2B and A3. Cells of the immune system …
Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases
BN Cronstein, M Sitkovsky - Nature Reviews Rheumatology, 2017 - nature.com
Adenosine, a nucleoside derived primarily from the extracellular hydrolysis of adenine
nucleotides, is a potent regulator of inflammation. Adenosine mediates its effects on …
nucleotides, is a potent regulator of inflammation. Adenosine mediates its effects on …
Regulation of inflammation by adenosine
G Haskó, B Cronstein - Frontiers in immunology, 2013 - frontiersin.org
Adenosine, a purine nucleoside generated by the dephosphorylation of adenine
nucleotides, is a potent endogenous physiologic and pharmacologic regulator of many …
nucleotides, is a potent endogenous physiologic and pharmacologic regulator of many …
Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation
MJL Bours, ELR Swennen, F Di Virgilio… - Pharmacology & …, 2006 - Elsevier
Human health is under constant threat of a wide variety of dangers, both self and nonself.
The immune system is occupied with protecting the host against such dangers in order to …
The immune system is occupied with protecting the host against such dangers in order to …
CD73: a potent suppressor of antitumor immune responses
Tumors use several strategies to evade immunosurveillance. One such mechanism is the
generation of adenosine within the tumor microenvironment, which potently suppresses …
generation of adenosine within the tumor microenvironment, which potently suppresses …
Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death
X Bao, L Xie - Journal of Experimental & Clinical Cancer Research, 2022 - Springer
Emerging evidence has demonstrated that radiotherapy (RT) can not only cause direct
damage to cancer cells but also lead to immunogenic cell death (ICD), which involves the …
damage to cancer cells but also lead to immunogenic cell death (ICD), which involves the …